Cargando…

VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment

Angiogenesis, a hallmark of cancer, is induced by vascular endothelial growth factor–A (hereafter VEGF). As a result, anti-VEGF therapy is commonly used for cancer treatment. Recent studies have found that VEGF expression is also associated with immune suppression in patients with cancer. This conne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yuqing, Huang, Huocong, Coleman, Morgan, Ziemys, Arturas, Gopal, Purva, Kazmi, Syed M., Brekken, Rolf A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675197/ https://www.ncbi.nlm.nih.gov/pubmed/34673569 http://dx.doi.org/10.1172/jci.insight.150735

Ejemplares similares

Perspectives on Hypoxia Signaling in Tumor Stroma
por: Zhang, Yuqing, et al.
Publicado: (2021)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression
por: Sui, Lufei, et al.
Publicado: (2022)

A role of proton transfer in peroxidase-catalyzed process elucidated by substrates docking calculations
por: Kulys, Juozas, et al.
Publicado: (2001)

Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium
por: Dellinger, Michael T., et al.
Publicado: (2011)

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
por: Steggerda, Susanne M., et al.
Publicado: (2017)

Lymphatic Transport Efficiency Determines Metastatic Potential of Cutaneous Melanoma
por: Holder, Ashley M., et al.
Publicado: (2020)

Targeting TNF-α–producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling
por: Dixit, Ajay, et al.
Publicado: (2022)

Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment
por: Cao, Jennifer, et al.
Publicado: (2023)

Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects
por: Chang, Yi-Wen, et al.
Publicado: (2014)

Dissecting the Lymphatic System to Predict Melanoma Metastasis
por: Suresh, Rishi, et al.
Publicado: (2020)

Seed- and Soil-Dependent Differences in Murine Breast Tumor Microenvironments Dictate Anti-PD-L1 IgG Delivery and Therapeutic Efficacy
por: Liu, Yan Ting, et al.
Publicado: (2021)

The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells
por: Giannotta, Claudia, et al.
Publicado: (2023)

Phosphatidylserine-targeting antibody induces M1 macrophage polarization, promotes myeloid derived suppressor cell differentiation and boosts tumor-specific immunity
por: Huang, Xianming, et al.
Publicado: (2013)

Attenuated Microcirculation in Small Metastatic Tumors in Murine Liver
por: Ziemys, Arturas, et al.
Publicado: (2021)

VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment
por: Jaal, Jana, et al.
Publicado: (2015)

The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
por: Mi, Yajing, et al.
Publicado: (2020)

Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy
por: Kai, Megumi, et al.
Publicado: (2019)

The protein kinase promiscuities in the cancer-preventive mechanisms of NSAIDs
por: Norvaisas, Povilas, et al.
Publicado: (2016)

MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2
por: Ghosh, Alip, et al.
Publicado: (2017)

GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
por: Lynn, Kristi D, et al.
Publicado: (2010)

Cinnamon extract inhibits angiogenesis in zebrafish and human endothelial cells by suppressing VEGFR1, VEGFR2, and PKC-mediated MAP kinase
por: Bansode, Rishipal R, et al.
Publicado: (2013)

The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors
por: Musca, Beatrice, et al.
Publicado: (2023)

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma
por: Jinnin, Masatoshi, et al.
Publicado: (2008)

5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia
por: Ebelt, Nancy D., et al.
Publicado: (2022)

Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
por: Sendker, Stephanie, et al.
Publicado: (2021)

Sialyllactose suppresses angiogenesis by inhibiting VEGFR-2 activation, and tumor progression
por: Chung, Tae-Wook, et al.
Publicado: (2017)

CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer
por: Racioppi, Luigi, et al.
Publicado: (2019)

Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer
por: Yang, Ju, et al.
Publicado: (2019)

Inhibition of VEGFR-2 Reverses Type 1 Diabetes in NOD Mice by Abrogating Insulitis and Restoring Islet Function
por: Villalta, S. Armando, et al.
Publicado: (2013)

The role and significance of VEGFR2(+) regulatory T cells in tumor immunity
por: Zhu, Panrong, et al.
Publicado: (2017)

VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
por: Zhao, Yueshui, et al.
Publicado: (2022)

Saikosaponin A, a Triterpene Saponin, Suppresses Angiogenesis and Tumor Growth by Blocking VEGFR2-Mediated Signaling Pathway
por: Zhang, Pan, et al.
Publicado: (2021)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Myeloid cells in circulation and tumor microenvironment of breast cancer patients
por: Toor, Salman M., et al.
Publicado: (2017)

PANCREATIC CANCER PROLIFERATION IS INDUCED BY GLI2-COL1 SIGNALING IN FIBROBLASTS IN THE TUMOR MICROENVIRONMENT
por: Ross, Madeline, et al.
Publicado: (2022)

Sustained Administration of Hormones Exploiting Nanoconfined Diffusion through Nanochannel Membranes
por: Geninatti, Thomas, et al.
Publicado: (2015)

Targeting VEGF/VEGFR to Modulate Antitumor Immunity
por: Yang, Ju, et al.
Publicado: (2018)

Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance
por: Holthof, Lisa C., et al.
Publicado: (2020)

A key role of GARP in the immune suppressive tumor microenvironment
por: Hahn, Susanne A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lb9okibrmot5ihcjemtp9498of